Recombinant Proteins From Plants Methods and Protocols /

Detalles Bibliográficos
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Faye, Loïc. (Editor ), Gomord, Veronique. (Editor )
Formato: eBook
Lenguaje:English
Publicado: Totowa, NJ : Humana Press : Imprint: Humana, 2009.
Edición:1st ed. 2009.
Colección:Methods in Molecular Biology, 483
Materias:
Acceso en línea:https://doi.org/10.1007/978-1-59745-407-0
Tabla de Contenidos:
  • From Neanderthal to Nanobiotech: From Plant Potions to Pharming with Plant Factories
  • Cowpea Mosaic Virus-Based Systems for the Expression of Antigens and Antibodies in Plants
  • Transient Expression of Antibodies in Plants Using Syringe Agroinfiltration
  • Rapid System for Evaluating Bioproduction Capacity of Complex Pharmaceutical Proteins in Plants
  • Production and Localization of Recombinant Pharmaceuticals in Transgenic Seeds
  • Production of Antibody Fragments in Arabidopsis Seeds
  • Production of Plantibodies in Nicotiana Plants
  • Physcomitrella patens : A Non-Vascular Plant for Recombinant Protein Production
  • Production of Recombinant Proteins in Suspension–Cultured Plant Cells
  • Chloroplast-Derived Vaccine Antigens and Biopharmaceuticals: Protocols for Expression, Purification, or Oral Delivery and Functional Evaluation
  • Protein Body Induction: A New Tool to Produce and Recover Recombinant Proteins in Plants
  • A Case Study for Plant-Made Pharmaceuticals Comparing Different Plant Expression and Production Systems
  • Glycosylation of Antibody Therapeutics: Optimisation for Purpose
  • N-Glycosylation of Plant Recombinant Pharmaceuticals
  • Companion Protease Inhibitors to Protect Recombinant Proteins in Transgenic Plant Extracts
  • Strategies for Improving Vaccine Antigens Expression in Transgenic Plants: Fusion to Carrier Sequences
  • Immunomodulation of Plant Function by In Vitro Selected Single-Chain Fv Intrabodies
  • On-Chip Detection of Low-Molecular-Weight Recombinant Proteins in Plant Crude Extracts by SELDI-TOF MS
  • Assessing the Risk of Undesirable Immunogenicity/ Allergenicity of Plant-Derived Therapeutic Proteins
  • Biosafety, Risk Assessment and Regulation of Plant-Made Pharmaceuticals.